Results 231 to 240 of about 23,910 (287)
Some of the next articles are maybe not open access.
Expert Opinion on Emerging Drugs, 2007
Anxiety disorders are the most common of the psychiatric disorders and are also associated with significant economic costs and impaired work productivity. The first-line pharmacotherapy of pharmatherapy for a number of anxiety disorders comprises selective serotonin re-uptake inhibitors (SSRIs) and serotonin and noradrenaline re-uptake inhibitors ...
Dan J. Stein
exaly +3 more sources
Anxiety disorders are the most common of the psychiatric disorders and are also associated with significant economic costs and impaired work productivity. The first-line pharmacotherapy of pharmatherapy for a number of anxiety disorders comprises selective serotonin re-uptake inhibitors (SSRIs) and serotonin and noradrenaline re-uptake inhibitors ...
Dan J. Stein
exaly +3 more sources
Nihon rinsho. Japanese journal of clinical medicine, 2012 Childhood anxiety disorders are traditionally treated with selective serotonin reuptake inhibitors (SSRIs). Other anxiolytics, including benzodiazepines, antihistamines, and buspirone are also used to treat anxiety and sleep disorders in youth ...
Tsuyoshi, Okamura, Shuichi, Awata
core +5 more sources
International Journal of Environmental Research and Public Health, 2021 Anxiolytics (N05B) are one of the most widely used pharmacological groups. This study aimed to analyze the progression of the consumption of anxiolytics (ATC classification: N05B) dispensed in pharmacies in Castile and Leon, Spain, from 2015 to 2020 ...
Miryam Sánchez-Díaz +1 more
exaly +2 more sources
DeckerMed Psychiatry, 2018
The underlying pathophysiology of anxiety disorders revolve around neurotransmitter transmission, the pharmacologic target of common medication treatments. Pharmacologic treatment of anxiety disorders generally consists of benzodiazepines for short-term relief of anxiety symptoms and antidepressants as a long-term therapy. Benzodiazepines use should be
David A. Beck, Christine L. Beck
+4 more sources
The underlying pathophysiology of anxiety disorders revolve around neurotransmitter transmission, the pharmacologic target of common medication treatments. Pharmacologic treatment of anxiety disorders generally consists of benzodiazepines for short-term relief of anxiety symptoms and antidepressants as a long-term therapy. Benzodiazepines use should be
David A. Beck, Christine L. Beck
+4 more sources
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1985
Sixty (60) out-patients with DSM III generalized anxiety disorder were treated after a 1-week placebo washout in a 4-week double-blind study with buspirone, diazepam and placebo; after which they were withdrawn abruptly from medication or assigned to a 2-week period of placebo.
J C, Pecknold +5 more
openaire +2 more sources
Sixty (60) out-patients with DSM III generalized anxiety disorder were treated after a 1-week placebo washout in a 4-week double-blind study with buspirone, diazepam and placebo; after which they were withdrawn abruptly from medication or assigned to a 2-week period of placebo.
J C, Pecknold +5 more
openaire +2 more sources